NYSE · ELAN
Elanco Animal Health Incorporated
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ELAN: Nov 06, 2026
Elanco Animal Health Incorporated Common Stock is expected to report earnings on 11/06/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $0.2. The reported EPS for the same quarter last year was $0.19.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.20 | $0.21 | $0.19 | 8 |
| Dec 2026 | $0.18 | $0.20 | $0.17 | 8 |
| Mar 2027 | $0.44 | $0.45 | $0.43 | 6 |
| Jun 2027 | $0.36 | $0.37 | $0.35 | 6 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · MarketBeat · The Motley Fool- Zacks · Oct 29, 11:00 AM EDTAPA Gears Up to Report Q3 Earnings: Here's How It Will FareAPA Corporation is set to report Q3 2026 results, with higher oil prices potentially boosting revenues, while rising operating expenses could pressure earnings.
- Zacks · Oct 28, 4:45 PM EDTEncompass Health (EHC) Q3 Earnings and Revenues Top EstimatesEncompass Health (EHC) delivered earnings and revenue surprises of +10.15% and +0.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- BNK Invest · Oct 27, 10:57 AM EDTDFSV, ARW, ELAN, BWA: ETF Outflow AlertLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Dimensional US Small Cap Value ETF (Symbol: DFSV) where we have detected an approximate $155.9 million dollar outflow — that's a 1.8% decrease week
- Zacks · Oct 22, 8:58 AM EDTIQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should KnowIQV is poised for y/y revenue and earnings growth in Q3, driven by stronger clinical research demand, solid bookings, AI adoption and operational efficiencies.
- Zacks · Oct 19, 11:10 AM EDTWill Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?Elanco Animal Health (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks · Oct 16, 8:40 AM EDTAre Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?Here is how Aveanna Healthcare (AVAH) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
- MarketBeat · Sep 26, 6:02 AM EDTElanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain GroundBullish or Bearish? Vetting Animal Health Care StocksElanco Animal Health (NYSE:ELAN) President and CEO Jeff Simmons outlined the company’s growth strategy, product launches, deleveraging plans and outlook for its pet health and farm animal businesses during the Bank of America H
- The Motley Fool · Sep 4, 4:45 PM EDTElanco Director Purchases 40,000 Shares for $936,000The purchase was valued at $936,000.
- BNK Invest · Aug 24, 1:57 PM EDTMonday 8/24 Insider Buying Report: ELAN, BWABargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we
- The Motley Fool · Aug 19, 10:00 AM EDTDirector's Confidence Visible as Elanco Leader Buys 10,000 SharesThe director upped their stake by 10,000 shares.
- BNK Invest · Aug 14, 4:40 PM EDTELAN Crosses Above Key Moving Average LevelIn trading on Friday, shares of Elanco Animal Health Inc (Symbol: ELAN) crossed above their 200 day moving average of $23.57, changing hands as high as $23.64 per share. Elanco Animal Health Inc shares are currently trading up about 5% on the day. The chart below shows the one
- The Motley Fool · Aug 12, 7:43 AM EDTElanco (ELAN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Elanco Animal Health Incorporated from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.